Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Washington D.c. Veterans Affairs Medical Center

Clinical trials sponsored by Washington D.c. Veterans Affairs Medical Center, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New combo therapy aims to shield kidneys in african american veterans Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 3 Not yet recruiting 1

New combo therapy aims to shield kidneys in african american veterans

Disease control Not yet recruiting

This study tests two drugs, finerenone and empagliflozin, in 30 African American veterans with diabetic kidney disease. The goal is to see if these drugs reduce kidney cell damage by measuring specific proteins in urine. Participants will take one or both drugs for 4 months to ch…

Phase 4 • Sponsor: Washington D.C. Veterans Affairs Medical Center • Aim: Disease control

Last updated Aug 23, 2026 00:00 UTC